BusStim-LLC-logo

About Us


Who We Are


Based upon our analysis of current events, reasonably foreseeable trends in the pharma industry, as well as our overall collective experiences, BusStim identified a void and/or gap in the traditional drug development model. To address this problem BusStim created a new business model opportunistically fills the void in the traditional drug delivery model, to create a seamless partnership between Big Pharma and the BioTech community, thereby successfully meeting the needs of both parties. 

MEET OUR TEAM


Stephen Yelity

President & CEO - Partner

About Stephen

Douglas Greene, MD

Vice President and Chief Medical Officer - Partner

About Douglas

Thomas Argentieri, Ph.D.

Vice President of Business Development & Alliance Management - Partner 

About Thomas

Paul Jeffrey

Vice President Business Development & Commercialization - Partner

About Paul

Jerome J Schentag, Pharm.D.

Vice President of Translational Research & Partner

About Jerome

H. Gregory Tillman

Vice President of Contracts & Legal - General Counsel & Partner

About Gregory

Abe Abuchowski

Corporate Development – Senior Advisor

About Abe
Share by: